Medicine-Molecular, Monetary, or More Than Both?

JAMA: The Journal of the American Medical Association

Volumn 274, Issue 4, 1995, Pages 331-334

  Eisenberg, Leon ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HEALTH CARE POLICY; MEDICAL PRACTICE; MOLECULAR GENETICS; PATIENT CARE; PRIORITY JOURNAL;

EID: 0029092760     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03530040059041     Document Type: Article

References (34)

1. Peabody FW. The care of the patient. JAMA. 1927;88:877-882.
2. Cook-Degan R. The Gene Wars: Science, Politics, and the Human Genome. New York, NY: WW Norton & Co; 1994.
3. Blaese RM, Culver KW. Gene therapy for primary immunodeficiency disease. Immunodeficiency Rev. 1992;3:329.
4. Berardi AC, Wang A, Levine JD, Lopez A, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science. 1995; 267:104-108.
5. Eisenberg L. What makes persons ’patients’ and patients ’well’? Am J Med. 1980;69:277-286.
6. Covinsky KE, Goldman L, Cook EF, et al, for the SUPPORT Investigators. The impact of serious illness on patients’ families. JAMA. 1994;272: 1839-1844.
7. Hartley RM, Epstein AM, Harris CM, McNeil BJ. Differences in ambulatory test ordering in England and America. Am J Med. 1987;82:513-517.
8. Brook RH, Kosecoff JB, Park RE, Chassin MR, Winslow CM, Hampton JR. Diagnosis and treatment of coronary disease: comparison of doctor's attitudes in the U.S.A. and the U.K. Lancet. 1988; 1:750-753.
9. Hampton JR, Harrison MJG, Mitchell JRA, Pritchard JS, Seymour C. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. BMJ. 1975;1:486-489.
10. Peterson MC, Holbrook JH, Hales DV, Smith NL, Staker LV. Contributions of the history of physical examination, and laboratory investigation in making medical diagnoses. West J Med. 1992; 156:163-165.
11. Franks P, Clancy CM, Nutting PA. Gatekeeping revisited: protecting patients from overtreatment. N Engl J Med. 1992;327:424-429.
12. Mumford E, Schlesinger HJ, Glass GV, Patrick C, Cuerdon T. A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry. 1984;141:1145-1158.
13. Hickson GB, Clayton EW, Entman SS, et al. Obstetricians’ prior malpractice experience and patients’ satisfaction with care. JAMA. 1994;272:1583-1587.
14. Entman SS, Glass CA, Hickson GB, Githens PB, Whetten-Goldstein K, Sloan FA. The relationship between malpractice claims history and subsequent obstetric care. JAMA. 1994;272:1588-1591.
15. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328:1237-1243.
16. Dawson NA, Vogelzang N. Prostate Cancer. New York, NY; John Wiley & Sons Inc; 1994.
17. Feldman AR, Kessler L, Myers MH, Naughtan MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med. 1986;315:1394-1397.
18. Montie JE, Wood DP Jr, Pontes E, et al. Adenocarcinoma of the prostate in cytoprostatectomy specimens removed for bladder cancer. Cancer. 1989; 63:381-385.
19. Garnick MB. Urologic cancer. In: Rubenstein E, Federman DD, eds. Scientific American Medicine. New York, NY: Scientific American Books; 1993;12(IX):1.
20. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-780.
21. US Preventive Services Task Force. Screening for prostate cancer. Am J Prev Med. 1994;10:187-193.
22. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE, for the Prostate Patient Outcomes Research Team. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650-2658.
23. Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology. 1993;42:622-629.
24. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-135.
25. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. JAMA. 1993;269:2633-2636.
26. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG Jr, Wennberg JE, for the Prostate Disease Patient Outcome Research Team. A structured literature review of treatment for localized prostate cancer. Arch Fam Med. 1993;2: 487-493.
27. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo B. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992;267:2191-2196.
28. Mulley AG. Outcomes research: implications for policy and practice. In: Delamothe T, ed. Outcomes Into Clinical Practice. London, England: BMJ Publishing Group; 1994:13-27.
29. Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JE. Watchful waiting vs immediate transurethral resection for symptomatic prostatism: the importance of patients’ preferences. JAMA. 1988;259: 3010-3017.
30. Hart JT. Two paths for medical practice. Lancet. 1992;340:772-775.
31. Ginzberg E. Monetarization of medical care. N Engl J Med. 1984;310:1162-1165.
32. McKinlay JB, Arches J. Toward the proletarianization of physicians. Int J Health Serv. 1985;15: 161-195.
33. McKinlay JB, Stoeckle JD. Corporatization and the social transformation of doctoring. Int J Health Serv. 1988;18:191-205.
34. Craft N. Secrecy in the NHS. BMJ. 1994;309: 1670-1673.